Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-13

Clinical Trial Update: A Drug-drug Interaction Study of Avapritinib and Midazolam [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study of avapritinib with midazolam has completed. The snippet does not provide study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avapritinib (avapritinib)
  • Midazolam (Midazolam)

Snippet

Sponsor: Blueprint Medicines Corporation | Conditions: Gastrointestinal Stromal Tumors, GIST | Phase 1 | Status: COMPLETED